Doxycycline Hydrochloride
7 Inquiries
10592-13-9
Pharmaceutical Grade
95%
Any China Port
2019-04-20
API,Intermediate
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Doxycycline hydrochloride
Other Name:2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrochloride (1:1),(4S,4aR,5S,5aR,6R,12aS)-;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrochloride;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrochloride,[4S-(4α,4aα,5α,5aα,6α,12aα)]-;2-Naphthacenecarboxamide,4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrochloride;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,6R,12aS)-;Deoxy-5-hydroxytetracycline hydrochloride;Doxycycline hydrochloride;Deoxyoxytetracycline hydrochloride;6-Deoxyoxytetracycline hydrochloride;α-6-Deoxy-5-hydroxytetracycline hydrochloride;Doxylin;Vibramycin hyclate;Vibramycin hydrochloride;Idocyklin;6-Desoxy-5-hydroxytetracycline hydrochloride;Farcodoxin;100929-47-3;53108-42-2;61281-03-6
CAS No.:10592-13-9
Molecular Formula:C22H24N2O8.ClH
InChIKeys:InChIKey=RUYHIJHUVHIMIR-CVHRZJFOSA-N
Molecular Weight:480.9
Exact Mass:480.129944
EC Number:234-198-7
UNII:4182Z6T2ET
NSC Number:756751|633557
DSSTox ID:DTXSID4041020|DTXSID1045405
NCI Thesaurus Code:C29010
HScode:29413000
Categories:
Characteristics-
PSA:
182
XLogP3:1.15470
Appearance:yellow
Density:1.63 g/cm3
Melting Point:195-201℃
Boiling Point:762.6°C at 760 mmHg
Flash Point:87℃
Water Solubility:soluble in water.H2O: 50 mg/mL, clear, yellow-green
Storage Conditions:0-6°C
Collision Cross Section:195.6 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.
Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.
Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Inquiry History7 Inquiries
Country Product Purchase Quantity Date Posted 
Egypt
Doxycycline hcl
150 KG Feb 5, 2025
Egypt
Doxycycline Hydrochloride
150 KG Jan 27, 2025 
Bangladesh
Doxycycline hydrochloride
200 KG Feb 16, 2026 
Nigeria
Doxycycline - Oxoid
1.00 KG Aug 9, 2025 
Pakistan
Doxycycline HCl
500 KG Nov 1, 2024 
United States
Doxycycline
1 KG Oct 1, 2024 
Netherlands
Doxycycline Hydrochloride
1 KG Feb 18, 2024 Post an enquiry for this product
